Transgene S.A.
TNG.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €114 | €90 | €103 | €139 |
| - Cash | €17 | €17 | €15 | €16 |
| + Debt | €31 | €10 | €0 | €1 |
| Enterprise Value | €128 | €83 | €88 | €124 |
| Revenue | €0 | €3 | €0 | €3 |
| % Growth | -96.8% | 12,926.1% | -99.3% | – |
| Gross Profit | €0 | -€16 | -€12 | -€11 |
| % Margin | 0% | -529.3% | -52,460.9% | -346.9% |
| EBITDA | -€22 | -€18 | -€19 | -€13 |
| % Margin | -22,958.3% | -615.5% | -80,617.4% | -429.2% |
| Net Income | -€19 | -€17 | -€16 | -€6 |
| % Margin | -20,099% | -583.6% | -71,673.9% | -204.8% |
| EPS Diluted | -0.15 | -0.13 | -0.16 | -0.063 |
| % Growth | -15.4% | 18.8% | -152.4% | – |
| Operating Cash Flow | -€18 | -€6 | -€18 | -€17 |
| Capital Expenditures | -€0 | -€1 | -€2 | -€1 |
| Free Cash Flow | -€18 | -€7 | -€20 | -€18 |